Oxazoles
Aobchem 1-(Chloromethyl)-4-methylbenzene | 95% | CAS 104-82-5 | C8H9Cl | 100g
1-(Chloromethyl)-4-methylbenzene | 95% | CAS 104-82-5 | C8H9Cl | 100g
Aobchem 2-Chloro-1-(chloromethyl)-4-methoxybenzene | ≥97% | CAS 101080-63-1 | C8H8Cl2O | 500mg
2-Chloro-1-(chloromethyl)-4-methoxybenzene | ≥97% | CAS 101080-63-1 | C8H8Cl2O | 500mg
Aobchem 2-Bromopyridine-5-carboxaldehyde | ≥97% | CAS 149806-06-4 | C6H4BrNO | 100g
2-Bromopyridine-5-carboxaldehyde | ≥97% | CAS 149806-06-4 | C6H4BrNO | 100g
Aobchem (4-Pentylphenyl)(propyl)sulfane | 97% | CAS 3002480-51-2 | C14H22S | 1g
(4-Pentylphenyl)(propyl)sulfane | 97% | CAS 3002480-51-2 | C14H22S | 1g
eMolecules 65373-52-6 | Oxazole-2-carbaldehyde | Combi-Blocks | MFCD03412587 | 97.073 | C4H3NO2 | 96.000 | O=Cc1ncco1 | 5g | 388717536
Oxazole-2-carbaldehyde | Combi-Blocks | 65373-52-6 | MFCD03412587 | 97.073 | C4H3NO2 | 96.000 | O=Cc1ncco1 | 5g | 388717536
eMolecules 3364-80-5 | 1,3-Thiazole-4-carboxaldehyde | Apollo Scientific US - Building Blocks | MFCD00626896 | 113.130 | C4H3NOS | 95.000 | O=Cc1cscn1 | 1g | 397999035
1,3-Thiazole-4-carboxaldehyde | Apollo Scientific US - Building Blocks | 3364-80-5 | MFCD00626896 | 113.130 | C4H3NOS | 95.000 | O=Cc1cscn1 | 1g | 397999035
Aobchem 2-Bromopyridine-5-carboxaldehyde | ≥97% | CAS 149806-06-4 | C6H4BrNO | 500g
2-Bromopyridine-5-carboxaldehyde | ≥97% | CAS 149806-06-4 | C6H4BrNO | 500g
Aobchem 2-Chloro-1-(chloromethyl)-4-methoxybenzene | ≥97% | CAS 101080-63-1 | C8H8Cl2O | 1g
2-Chloro-1-(chloromethyl)-4-methoxybenzene | ≥97% | CAS 101080-63-1 | C8H8Cl2O | 1g
eMolecules 3364-80-5 | 1,3-Thiazole-4-carboxaldehyde | Apollo Scientific | MFCD00626896 | 113.130 | C4H3NOS | 95.000 | O=Cc1cscn1 | 5g | 562427929
1,3-Thiazole-4-carboxaldehyde | Apollo Scientific | 3364-80-5 | MFCD00626896 | 113.130 | C4H3NOS | 95.000 | O=Cc1cscn1 | 5g | 562427929
Medchemexpress LLC Racemic 2-propyl-4-pentenoic acid | 1575-72-0 | MFCD00869309 | 98.0% | 142.20 g/mol | C8H14O2 | 50MG
(±)-2-Propyl-4-pentenoic acid (4-en-VPA) is the racemic form of a known toxic metabolite of valproic acid used as an analytical and research standard for studies of metabolism and developmental toxicity. The material is supplied as a high-purity solid suitable for analytical workflows and toxicology research, and is provided in small pack sizes for laboratory use.
- High purity suitable for analytical applications.
- Provided as a solid powder for convenient handling.
- Relevant for metabolism and neuroteratogenicity studies.
- Available in small pack sizes for research-scale experiments.
- Supplied with supplier-specified analytical data and handling recommendations.
eMolecules 65373-52-6 | OXAZOLE-2-CARBALDEHYDE | AstaTech | MFCD03412587 | 97.073 | C4H3NO2 | 95.000 | O=Cc1ncco1 | 1g | 384829856
OXAZOLE-2-CARBALDEHYDE | AstaTech | 65373-52-6 | MFCD03412587 | 97.073 | C4H3NO2 | 95.000 | O=Cc1ncco1 | 1g | 384829856
Medchemexpress LLC VISTA/B7-H5 Rat HE 10ug
VISTA/B7-H5 protein an immunoregulatory receptor inhibits T-cell response and may regulate embryonic stem cell differentiation by inhibiting BMP4 signaling It also stimulates MMP14-mediated MMP2 activation suggesting a role in matrix metalloproteinase processes These roles highlight the significance of VISTA/B7-H5 in immune regulation embryonic development and extracellular matrix dynamics VISTA/B7-H5 Protein Rat (HEK293 Fc) is the recombinant rat-derived VISTA/B7-H5 protein expressed by HEK293 with C-hFc labeled tag
eMolecules 1935087-98-1 | 5-Bromo-oxazole-2-carboxylic acid | J & W PharmLab LLC191.968 | C4H2BrNO3 | 95.000 | OC(=O)c1ncc(Br)o1 | 1g | 553408709
5-Bromo-oxazole-2-carboxylic acid | J & W PharmLab LLC | 1935087-98-1191.968 | C4H2BrNO3 | 95.000 | OC(=O)c1ncc(Br)o1 | 1g | 553408709
eMolecules 1936295-52-1 | 4-Bromo-oxazole-2-carboxylic acid methyl ester | J & W PharmLab LLC | MFCD28369453 | 205.995 | C5H4BrNO3 | 96.000 | COC(=O)c1nc(Br)co1 | 1g | 495795596
4-Bromo-oxazole-2-carboxylic acid methyl ester | J & W PharmLab LLC | 1936295-52-1 | MFCD28369453 | 205.995 | C5H4BrNO3 | 96.000 | COC(=O)c1nc(Br)co1 | 1g | 495795596